Search
for
Sort by
Research 751–780 of 1000+
- Comparison of Intraoperative Blood Loss in Patients With Benign Prostatic Hyperplasia Undergoing Bipolar Transurethral Resection of the Prostate With and Without Preoperative Oral Finasteride
- Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality
- Androgen receptor-mediated gene activation in prostate cancer cells
- Association between Androgenic Hair Patterns and Prostate Cancer Risk in South Indian Men: A Case-control Study from the Cauvery Delta.
- Re: Long-Term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial
- Konvergentna validacija farmakoekonomskih aspekata terapije benigne hiperplazije prostate u Crnoj Gori
- Faculty Opinions recommendation of Screening for prostate cancer.
- 1452 DETECTION RATE OF CLINICALLY INSIGNIFICANT PROSTATE CANCER INCREASES WITH REPEATING PROSTATE BIOPSIES
- Paradigm Shift in the Concept of Hormonal Milieu of Prostate Cancer
- S3 SERUM TRIGLYCERIDE CONCENTRATION AND RISK OF PROSTATE CANCER: A PROSPECTIVE MULTICENTER STUDY
- Estudio clínico-patológico sobre el cáncer de próstata incidental en pacientes intervenidos bajo el supuesto diagnóstico de HBP sintomática
- Tratamientos fitoterapeúticos para la hipertrofia benigna de próstata: serenoa repens
- Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate Cancer
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Androgen Receptor Mutations and Polymorphisms in African American Prostate Cancer
- Multiple readout assay for hormonal (androgenic and antiandrogenic) and cytotoxic activity of plant and fungal extracts based on differential prostate cancer cell line behavior
- In vitro [7-3H]-testosterone metabolism by the rat ventral prostate—Effect of some exogenous compounds
- Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment
- Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study
- Modulation of the canonical Wnt activity by androgen signaling in prostate epithelial basal stem cells
- Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2
- Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
- Re: Association of Treatment with 5α-Reductase Inhibitors with Time to Diagnosis and Mortality in Prostate Cancer
- Alopecia androgénica como factor predictor de hiperplasia benigna de próstata
- Topical Application of Thermobalancing Therapy Enabled by Therapeutic Device Treats Enlarged Prostate and Improves Men's Quality of Life; New Opportunity in BPH Treatment
- 342 COMPARISON OF THE INCIDENCE OF SECONDARY CANCERS AFTER IMRT, BRACHYTHERAPY AND SURGERY FOR THE TREATMENT OF PROSTATE CANCER
- UP-02.009 Clinical Significance of Intravesical Prostatic Protrusion/Prostate Volume
- S88 Does cone beam computed tomography decrease CTV's margins in prostate cancer radiation treatment?
- S87 Image guided radiotherapy (IGRT) in stage III prostate cancer: analysis of acute toxicity
- Control of testosterone 5alpha-reductase activity in the human hyperplastic prostate